Efficacy of nivolumab as second line treatment for recurrent or metastatic Head and Neck Squamous Cell Carcinoma: A national DAHANCA cohort study

Sebastian Søby*, Anita Gothelf, Niels Gyldenkerne, Jens Bentzen, Kinga Nowicka-Matus, Trine Tramm, Jesper Grau Eriksen

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Tidsskriftartikel › Forskning › peer review

3 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Efficacy of nivolumab as second line treatment for recurrent or metastatic Head and Neck Squamous Cell Carcinoma: A national DAHANCA cohort study'. Sammen danner de et unikt fingeraftryk.

Medicine and Dentistry

Immunology and Microbiology